Stifel has recently initiated Janux Therapeutics Inc (JANX) stock to Buy rating, as announced on September 6, 2024, according to Finviz. Earlier, on May 30, 2024, Scotiabank had initiated the stock to ...

StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

CME Group Inc. is amping up the battle for market share in US Treasury futures, pulling all stops to thwart Howard Lutnick’s ...

Without a loan from the German government and the matching funds from the State of Bavaria, Lilium N.V. (NASDAQ:LILM) will ...

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

PagSeguro Digital (NYSE:PAGS – Get Free Report) had its price objective lowered by research analysts at Barclays from $16.00 ...

In Arizona, older people recently received a mailer declaring Medicare had been cancelled. It had a big red stamp that ...